Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
As of February 18, 2026, the class has expanded with established agents like semaglutide, liraglutide, dulaglutide, and exenatide, alongside dual GLP-1/GIP agonists such as tirzepatide, which are often discussed in GLP-1 contexts due to overlapping mechanisms and indications
These obstacles significantly restrict their absorption and therapeutic effectiveness, necessitating chemical changes to optimize their pharmacokinetics
Both can lead to the same result
They possess a symmetric core with tree-like branches called dendrons, which are capable of encapsulating drugs
Strategies to extend thrornbolytic time window for Ischernic stroke treatment: an unmet clinical need
101 The current use of bacterial-derived L-asparaginase (ASNase) in pediatric acute lymphoblastic leukemia (ALL) has significantly improved cure rates
US$ 24.28
US$ 25.70
US$ 27.93
US$ 29.59